Search clinical trials for: Arbovirus Infections

Total 56369 results

University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program; Institut Pasteur; MRC/UVRI... and other collaborators

Completed

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine (NIFTY)

Yellow Fever

Kenya, Uganda
Takeda

Completed

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Dengue Fever

Thailand
Takeda

Active, not recruiting

Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children (TIDES)

Healthy Volunteers

Thailand, Brazil, Colombia, Dominican Republic, Nicaragua, Panama, Philippines, Sri Lanka
National Institute of Allergy and Infectious Diseases...

Completed

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (DNA)

RNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral Diseases

United States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
Pfizer

Completed

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Encephalitis, Tick-Borne

Austria, Czechia
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia (CYD00082)

Dengue Fever

Colombia
Sanofi Pasteur, a Sanofi Company

Completed

Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy

Dengue Virus Infection

Brazil
Centre Hospitalier Universitaire de la Réunion

Completed

Consequences of a Maternal-fetal Chikungunya Virus Infection (CHIK13+)

Chikungunya Virus Infection

Réunion
Serum Institute of India Pvt. Ltd.
PPD Australia Pty Ltd

Completed

A Phase 1 Safety Study of Dengusiil in Healthy Adults

Prevention of Dengue Fever

Australia
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Institute of Technology Transfer and Innovation (ITTI)

Completed

Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial

Dengue

Bangladesh
Universidad de Antioquia

Completed

Educational Intervention to Promote Control Behaviors and Prevention of Dengue

Dengue

Colombia
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation

Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination

Yellow Fever Vaccine

United States
Massachusetts General Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico

Adherence, Patient | Zika Virus Infection

Puerto Rico
Bavarian Nordic
Emergent BioSolutions

Completed

A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317

Chikungunya Virus

United States
University of Pennsylvania
Inovio Pharmaceuticals

Completed

A Study of INO-A002 in Healthy Dengue Virus-naive Adults

Healthy Volunteers

United States
University of Malaya
Ministry of Health, Malaysia

Completed

Effectiveness Evaluation of a Dengue Self-monitoring System (DeSMoS)

Dengue

Malaysia
Pfizer

Completed

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Tick-Borne Encephalitis

Japan
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of Dengue RDTs

Dengue Fever

Pakistan
Centre Hospitalier Universitaire de la Réunion

Active, not recruiting

Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island (DENGUE-RUN)

Dengue Fever With Warning Signs

France
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

Yellow Fever | Yellow Fever Immunisation

United States
Valneva Austria GmbH

Completed

Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults

Chikungunya Virus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas

Zika Virus

Puerto Rico, United States
Bavarian Nordic
Emergent BioSolutions; Catalyst Clinical Research, LLC

Completed

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Chikungunya Virus

United States
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Metformin in Dengue With Obesity (MeDO)

Obesity | Overweight | Dengue | Viral Infection | Metformin | Anti-inflammatory Agents

Vietnam
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

Yellow Fever

United States, Uganda
George Washington University

Enrolling by invitation

Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)

Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity

Colombia
US Army Medical Research Institute of Infectious...

Completed

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Yellow Fever Vaccination Reaction

United States
Phramongkutklao College of Medicine and Hospital

Completed

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

Dengue | Dengue With Warning Signs | Dengue Shock Syndrome

Thailand
Bavarian Nordic
Emergent BioSolutions

Completed

A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine (CHIKV VLP)

Chikungunya Virus

United States
Bavarian Nordic
Walter Reed Army Institute of Research (WRAIR); Emergent BioSolutions

Completed

Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (WRAIR)

Chikungunya

United States
Bavarian Nordic
Emergent BioSolutions

Completed

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

Chikungunya Virus Infection

United States
Valneva Austria GmbH

Completed

Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

Chikungunya Virus Infection

United States
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (VYF02)

Yellow Fever (Healthy Volunteers)

United States
The Immunobiological Technology Institute (Bio-Manguinhos)...
Ministry of Health, Brazil

Active, not recruiting

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

Immunity | Yellow Fever Vaccine

Brazil
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom
University of the Philippines
World Health Organization; University of North Carolina; International Vaccine... and other collaborators

Active, not recruiting

Dengue Serostatus Study in the Philippines

Dengue | Dengue Fever | Severe Dengue | Virologically-confirmed Dengue
University of the Philippines
Sanofi Pasteur, a Sanofi Company; Research Institute for Tropical Medicine,...

Completed

Dengue Effectiveness Study in the Philippines

Dengue | Severe Dengue | Virologically Confirmed Dengue

Philippines
Atea Pharmaceuticals, Inc.

Terminated

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Dengue

United States
International Vaccine Institute

Active, not recruiting

Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia (IVICHIK001)

Chikungunya

Colombia, Costa Rica, Guatemala, Panama, Thailand
Pfizer

Completed

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Encephalitis, Tick-Borne

Poland
Takeda

Completed

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Healthy

Colombia, Singapore, Thailand, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

Zika Virus Infection

Puerto Rico
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Valneva Austria GmbH

Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)

Chikungunya Virus Infection

United States
Karius, Inc.
Tribhuvan University, Nepal

Completed

Detection of Dengue Virus in Plasma of Patients in Nepal

Dengue Fever

Nepal
Beth Kirkpatrick
International Centre for Diarrhoeal Disease Research, Bangladesh

Active, not recruiting

Dengue Controlled Human Infection Model in Dhaka, Bangladesh

Dengue

Bangladesh
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Human Immunodeficiency Virus | Dengue Fever | Dengue Hemorrhagic Fever

Brazil
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
National Taiwan University Hospital
Centers for Disease Control, Taiwan

Completed

Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan

Dengue

Taiwan

Search clinical trials for: Arbovirus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations